research Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.
Search
forClinics
6 / 12 results- 38
Hair Loss TreatmentsThe Ageless ClinicColombo · LK - 50Hair TransplantHair Loss TreatmentsDermatologyThe Derma TheoryBengaluru, Karnataka · IN
- 61
Hair Loss TreatmentsHair TransplantSMPThe Paragon Hair ClinicMansfield, TX · US - 37Hair TransplantThe Eden Aesthetics Skin Laser & Hair Transplant ClinicVisakhapatnam, Andhra Pradesh · IN
- 66
Hair TransplantSMPHair Loss TreatmentsThe Hair & Cosmetic Dermatology CenterChesterfield, MO · US - 59
Hair TransplantTHE DERMALUXE DERMATOLOGY & AESTHETIC CLINICBhavnagar, Gujarat · IN
Experts
6 / 20 results- 71SMP Specialist
The SMP Guy
Oldham, United Kingdom
- 69
Hair Transplant SurgeonDr. Theo Birch, MBBS, FRACS
Central Coast, NSW, Australia
- 15Hair Transplant Surgeon
Dr. Thế Hanh
Hanoi, Vietnam
- 12Hair System Specialist
The Standard
Ouahigouya, Burkina Faso
- 37
Hair Loss SpecialistThe Tran, PA-C
Arlington, TX, United States
- 36Hair Loss Specialist
Thuy Nguyen, PA-C
Mission Viejo, CA, United States
Research
4 / 1000+ results research Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.
research A novel therapeutic paradigm for patients with extensive alopecia areata
New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.
research 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.
Learn
— no results
Community Join
— no results